Phase II Study of Neo-adjuvant Chemoradiotherapy for Squamous Cell Esophageal Cancer

NCT02938195 · clinicaltrials.gov ↗
PHASE2
Phase
UNKNOWN
Status
50
Enrollment
OTHER
Sponsor class

Conditions

Interventions

Sponsor

Shanghai Chest Hospital